A Smarter Path to an Early Exit
Services
Whether you're just beginning to contemplate an exit or require an accelerated M&A effort, we can help
Practical guidance for founders who prefer to explore options independently.
The Medtech Early Exit Prep Toolkit gives you a structured framework to evaluate your company’s readiness, identify acquirers, and prepare the essentials for early-stage M&A — at your own pace.
It’s the same roadmap we use in advisory engagements, distilled for self-directed founders and boards.
Ideal for: Founders and physician-inventors exploring exit timing or preparing to engage advisors later.
Your personalized strategy for a premium, founder-aligned exit
We combine exit feasibility, market positioning, and buyer mapping into one focused process designed to reveal your most realistic and rewarding exit paths.
No inflated promises. Just clear options, readiness insights, and recommendations that lead to genuine acquirer interest.
Ideal for: Founders seeking clarity, board alignment, or investor confidence before starting exit discussions.
From first acquirer contact to signed agreement — handled with precision and care
Many founders want the outcome, not the orchestration. We manage the deal process, coordinate diligence, and protect your interests while maintaining trust on both sides.
Our goal: a deal you’re proud to have made — and relationships you’ll keep long after closing.
Ideal for: Founders ready to move forward with acquirer discussions but needing discreet, expert representation.
Why Founders Work With Us
Specialized in Early Medtech Exits
We focus exclusively on sub-$25M transactions — where expertise, discretion, and timing matter most.
Balanced for Both Science and Strategy
We understand medical technology and we speak the language of physician-inventors and technical founders.
Partnership-Driven Outcomes
We build relationships with acquirers that result in durable, win–win deals for you, your investors, and the patients you serve.